News & Events about Alpha Tau Medical Ltd Cl A.
First patient treated in the feasibility and safety study of intratumoral diffusingalpha radiation emitters for the treatment of advanced inoperable pancreatic cancer.
Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial
First ...
JERUSALEM, March 12, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the Company) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, today issued the following statement on Silicon Valley Bank (SVB) in response to questions from ...
Neovasc (NASDAQ:NVCN Get Rating) and Alpha Tau Medical (NASDAQ:DRTS Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership...
JERUSALEM, March 03, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the Company) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that the Israeli Ministry of Environmental Protection has granted the Company an ...
JERUSALEM, March 01, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the Company) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that it has received authorization from Health Canada to proceed with a feasibility and...